Literature DB >> 1089006

Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.

M A Sperling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1089006      PMCID: PMC1130263     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  150 in total

1.  Oral contraceptives and thromboembolic disease.

Authors:  V A Drill; D W Calhoun
Journal:  JAMA       Date:  1968-09-30       Impact factor: 56.272

2.  Tinea nigra palmaris.

Authors:  J M O'Donnell; R McAleer
Journal:  Med J Aust       Date:  1968-08-10       Impact factor: 7.738

3.  Oral contraception and elevated blood pressure.

Authors:  J E Tyson
Journal:  Am J Obstet Gynecol       Date:  1968-03-15       Impact factor: 8.661

4.  Investigation of relation between use of oral contraceptives and thromboembolic disease.

Authors:  M P Vessey; R Doll
Journal:  Br Med J       Date:  1968-04-27

5.  Steroid hormone excretion pattern in women with endometrial carcinoma.

Authors:  F de Waard; J H Thyssen; W Veeman; P C Sander
Journal:  Cancer       Date:  1968-11       Impact factor: 6.860

6.  Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women.

Authors:  A L Herbst; H Ulfelder; D C Poskanzer
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

7.  Serum copper and zinc levels in patients taking oral contraceptives.

Authors:  J G Schenker; S Hellerstein; E Jungreis; W Z Polishuk
Journal:  Fertil Steril       Date:  1971-04       Impact factor: 7.329

8.  Blood glucose and plasma insulin levels with ethynodiol diacetate oral contraceptive.

Authors:  J A Goldman; B Eckerling; Z Zukerman; S Mannheimer
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-03

9.  Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.

Authors:  W H Inman; M P Vessey
Journal:  Br Med J       Date:  1968-04-27

10.  Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons.

Authors:  C J Glueck; R I Levy; D S Fredrickson
Journal:  Ann Intern Med       Date:  1971-09       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.